Contents
Special Issue Topic

Angiotensins—A Century of Progress

Guest Editors

Dr. Carlos M. Ferrario E-Mail

Professor, General Surgery, Wake Forest School of Medicine, Winston-Salem, USA

Research Keywords: Biochemical physiology of the renin angiotensin aldosterone system, neurohormonal regulation of blood pressure, essential hypertension and its mechanisms

Dr. Leanne Groban E-Mail

Professor, Anesthesiology, Wake Forest School of Medicine, Winston-Salem, USA

Research Keywords: Sex differences in the pathophysiology of cardiovascular disease, aging and diastolic dysfunction, women’s heart health, diabetes and menopause

About the Special lssue

“The history of hypertension is both long and short”, so it was stated in the Preface to Angiotensin, Angiotensin, a book edited by Irvine H Page and F. Merlin Bumpus in 1974. Sixty-six years of continuous progress since the research of Skeggs et al. (PMCID: PMC2136385) isolation of angiotensin, the importance of this hormone, a product of the humoral system conceptualized as the renin angiotensin aldosterone system (RAAS) are pillars sustaining the development and applicability of medicines having a definitive impact in human disease, above and beyond their applicability to the treatment of diseases of the heart and the blood vessels. The multiplicity of the actions of the peptide hormones expressed within the RAAS continues to shed new light into human biology, tissue homeostasis, and the development of chronic non-communicable diseases. To celebrate these accomplishments and provide a forward look to RAAS participation in human disease, this special issue will highlight the major contributions to the understanding of the functions of angiotensins not only within and beyond its applicability to control of tissue perfusion, organ metabolic processes, inflammation, innate immunity, and fetal programming. And this issue welcomes diverse types of articles, including Original Article, Review, Meta-analysis, Systematic Review, Case Report, and Commentary.

The Editors believe that this special issue of Exploration of Medicine will allow the scientific community to reflect how far we have advanced in the frontiers of knowledge, where accepted knowledge of the system may need revision, and target the new frontiers of discovery in reaching ultimate knowledge of how hormones act to both regulate and dysregulate body homeostasis.

Keywords: Angiotensins, renin, angiotensinogen, heart diseases, vascular diseases, stroke, heart failure, chronic kidney disease, pregnancy, fetal programming, age-related mobility/disability, sepsis, surgery/anesthesia-related hypotension, sex differences

Published Articles

Open Access Original Article
High salt induced augmentation of angiotensin II mediated hypertension is associated with differential expression of tumor necrosis factor-alpha receptors in the kidney
Aim: Chronic high salt (HS) intake causes minimal changes in blood pressure (BP) but it induces augmented hypertensive response to angiotensin II (AngII) administration in rodents. The mechanism
Published: April 26, 2022 Explor Med. 2022;3:205–218
2180 63 3
Open Access Original Article
Development of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study
Aim: While it is commonly thought that left ventricular (LV) systolic function may insidiously deteriorate in hypertensive patients, few prospective data are available to support this notion.
Published: April 02, 2022 Explor Med. 2022;3:160–172
2032 42 2
Open Access Original Article
Incident left bundle branch block predicts cardiovascular events and death in hypertensive patients with left ventricular hypertrophy. The LIFE Study
Aim: Whether incident left bundle branch block (LBBB) is associated with increased cardiovascular (CV) morbidity and mortality in treated hypertensive patients with left ventricular hypertrophy (
Published: March 29, 2022 Explor Med. 2022;3:149–159
2958 40 1
Open Access Original Article
Incident atrial fibrillation and heart failure in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study
Aim: The present study investigated the appearance and severity of atrial fibrillation (AF) and heart failure (HF) in 8,702 hypertensive patients with left ventricular hypertrophy (LVH) receiving
Published: March 23, 2022 Explor Med. 2022;3:139–148
2280 38 3
Open Access Original Article
Time-varying serum uric acid predicts new-onset atrial fibrillation in treated hypertensive patients. The LIFE Study
Aim: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study showed less new-onset atrial fibrillation (AF) in hypertensive patients receiving losartan- vs. atenolol-based t
Published: March 17, 2022 Explor Med. 2022;3:128–138
2141 50 2
Open Access Original Article
Placental CD4+ T cells from preeclamptic patients cause autoantibodies to the angiotensin II type I receptor and hypertension in a pregnant rat model of preeclampsia
Aim: Preeclampsia (PE) is a hypertensive disorder of pregnancy associated with activated CD4+ T cells and autoantibodies to angiotensin II type 1 receptor (AT1-AA). We have previously
Published: February 25, 2022 Explor Med. 2022;3:99–111
2426 64 13
Open Access Review
Role of angiotensin II in the development of subcellular remodeling in heart failure
The development of heart failure under various pathological conditions such as myocardial infarction (MI), hypertension and diabetes are accompanied by adverse cardiac remodeling and cardiac dysfunction. Since heart function is mainly determined by coordinated activities of different subcellular organelles including sarcolemma, sarcoplasmic reticulum, mitochondria and myofibrils for regulating the intracellular concentration of Ca2+, it has been suggested that the occurrence of heart failure is a consequence of subcellular remodeling, metabolic alterations and Ca2+-handling abnormalities in cardiomyocytes.
Published: August 31, 2021 Explor Med. 2021;2:352–371
4264 71 19
Open Access Review
Angiotensin-(1-7) and Mas receptor in the brain
The renin-angiotensin system (RAS) is a key regulator of blood pressure and electrolyte homeostasis. Besides its importance as regulator of the cardiovascular function, the RAS has also been associated to the modulation of higher brain functions, including cognition, memory, depression and anxiety. For many years, angiotensin II (Ang II) has been considered the major bioactive component of the RAS. However, the existence of many other biologically active RAS components has currently been recognized, with similar, opposite, or distinct effects to those exerted by Ang II.
Published: June 30, 2021 Explor Med. 2021;2:268–293
7772 256 14
Open Access Review
Angiotensin peptides in the regulation of adrenal cortical function
The adrenal cortex plays a key role in the regulation of metabolism, salt and water homeostasis and sex differentiation by synthesizing glucocorticoid, mineralocorticoid and androgen hormones. Evidence exists that angiotensin II regulates adrenocortical function and it has been contended that angiotensin peptides of the non-canonical branch of the renin angiotensin system (RAS) might also modulate steroidogenesis in adrenals. Thus, the aim of this review is to examine the role of the RAS, and particularly of the angiotensin peptides and their receptors, in the regulation of adrenocortical hormones with particular focus on aldosterone production.
Published: June 30, 2021 Explor Med. 2021;2:294–304
4449 132 4
Open Access Original Article
Angiotensin-(3-4) modulates the overweight- and undernutrition-induced ACE2 downregulation in renal proximal tubule cells: implications for COVID-19?
Aim: The renal lesions–including severe acute kidney injury–are severe outcomes in severe acute respiratory syndrome coronavirus 2 infections. There are no reports regarding the influence of the nutritional status on the severity and progress of these lesions. Ageing is also an important risk factor. Methods: In the present study we compared the influence of overweight and undernutrition on the levels of renal angiotensin converting enzymes 1 and 2 (ACE and ACE2), which were evaluated by Western blotting. Since the renin-angiotensin-aldosterone system (RAAS) has been implicated in the progress of kidney failure during coronavirus disease 2019, the influence of Angiotensin-(3-4) [Ang-(3-4)] was investigated. Ang-(3-4) is the shortest angiotensin-derived peptide, which is considered the physiological antagonist of several Ang II effects.
Published: April 30, 2021 Explor Med. 2021;2:135–145
3242 108 2